Related Experiment Video

Updated: Aug 18, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells

Sanne Weijzen1, Paola Rizzo, Mike Braid

  • 1Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA.

Nature Medicine
|August 20, 2002
PubMed

Insights

Oncogenic Ras signaling activates wild-type Notch-1, which is essential for maintaining cancer cell characteristics. This discovery highlights Notch signaling as a potential new target for cancer therapies.

Area of Science:

  • Molecular biology
  • Oncology
  • Cell signaling

Background:

  • Truncated Notch receptors exhibit transforming activity.
  • The role of wild-type Notch signaling in neoplastic transformation is not well understood.
  • Ras signaling is frequently deregulated in human cancers and is a key therapeutic target.

Purpose of the Study:

  • To investigate the role of wild-type Notch signaling in Ras-mediated neoplastic transformation.
  • To elucidate the molecular mechanisms by which oncogenic Ras influences Notch signaling.
  • To identify potential novel therapeutic targets in Ras-driven cancers.

Main Methods:

  • Utilized in vitro and in vivo models of Ras-transformed human cells.
  • Assessed Notch signaling levels and activity.
  • Investigated the expression of Notch ligand Delta-1 and presenilin-1.
  • Examined the involvement of the p38-mediated pathway.

Main Results:

  • Oncogenic Ras activates wild-type Notch signaling.
  • Wild-type Notch-1 is necessary for maintaining the neoplastic phenotype in Ras-transformed cells.
  • Oncogenic Ras upregulates intracellular Notch-1, Delta-1, and presenilin-1 via a p38-mediated pathway.

Conclusions:

  • Notch signaling is a key downstream effector of oncogenic Ras.
  • Wild-type Notch-1 plays a critical role in Ras-driven neoplastic transformation.
  • Notch signaling represents a potential novel therapeutic target for cancers with deregulated Ras signaling.

More Related Videos

Real-time Bioluminescence Imaging of Notch Signaling Dynamics during Murine Neurogenesis10:25

Real-time Bioluminescence Imaging of Notch Signaling Dynamics during Murine Neurogenesis

Published on: December 12, 2019

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis07:26

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis

Published on: April 1, 2022

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...